Providers/Grant Support
This activity is provided by PRIME Education. There is no fee to participate. This activity is supported by an educational grant from Gilead Sciences, Inc.
Credits Available
- 0.5 CME/CE for Physicians (ACCME)
- 0.5 CME/CE for Physician Assistants (AAPA)
- 0.5 CH/CE for Nurse Practitioners (AANP)
- 0.5 CPE for Pharmacists (ACPE + NABP)
- 0.5 CNE for Nurses (ANCC)
Target Audience
Medical oncologists and their breast cancer clinical care teams (NPs, PAs, nurses, and pharmacists).
Program Overview
Novel therapies are improving the outlook for patients with endocrine-refractory HR+/HER2- breast cancer, but their unique adverse event profiles require proactive, evidence-based management. Staying current on adverse event management and supportive care are essential to maximize the clinical benefits and preserve quality of life.
In this interactive Clinical Case Challenge, you will:
- Assess your knowledge of evidence-based monitoring and management of adverse events with novel systemic therapies for HR+/HER2- breast cancer
- Explore practical strategies for multidisciplinary collaboration in providing patient-centered supportive care
- Gain expert insights and patient perspectives with video-based discussions
- Receive immediate, evidence-supported feedback to improve your clinical skills in patient-centered supportive care and toxicity management.
Learning Objectives
- Evaluate recent guidelines and clinical trial data for the management and treatment sequencing of endocrine-refractory, HR+/HER2- breast cancer (BC), including the role of antibody-drug conjugates (ADCs)
- Design effective strategies for preventing and managing adverse events (AEs) with novel systemic therapies, including neutropenia, gastrointestinal toxicities, and interstitial lung disease (ILD)
Faculty
Lisa A. Carey, MD
Speaker and Contributing Editor
Meredith Maguire, PA
Speaker
Kathleen Duppler
Contributing Author
Planners/Reviewers
Ricardo Correa, MD, EdD, FACP, FACE, FAPCR, FACMQ - Planner
Lisa Wakefield, MSN, APRN, FNP-BC - Planner
Stephanie Joyce, PA, MSPAS, MS, RD - Peer Reviewer
Joint Accreditation Statement
In support of improving patient care, PRIME® is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurse Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Interprofessional Teams
This activity was planned by and for the healthcare team, and learners will receive 0.5 Interprofessional Continuing Education (IPCE) credits for learning and change.
Physician Credit Designation Statement
PRIME® designates the Enduring material for a maximum of 0.5 AMA PRA Category 1 Credits™. Physicians should claim only credit commensurate with the extent of their participation in the activity.
Physician Assistant Accreditation Statement
PRIME® has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.5 AAPA Category 1 CME Credit. Approval is valid until 12/11/2025. PAs should only claim credit commensurate with the extent of their participation.
Nurse Practitioner Accreditation Statement
PRIME Education is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 060815. This activity is approved for 0.5 contact hour (which includes 0.35 hour of pharmacology).
Pharmacist Accreditation Statement
This Knowledge-based activity has been approved for 0.5 contact hour (0 CEUs) by PRIME® for pharmacists. The Universal Activity Number for this activity is JA0007144-0000-24-356-H01-P. Pharmacy CE credits can be submitted to the NABP upon successful completion of the activity by providing your NABP ID & DOB, which must be submitted within 60 days of completion. Pharmacists with questions can contact NABP customer service ([email protected]).
Nurse Accreditation Statement
PRIME® designates this activity for 0.5 contact hour.
Disclosures of Conflict of Interest
*PRIME® has identified, reviewed, and mitigated all relevant financial relationships that speakers, authors, course directors, planners, peer reviewers, or relevant staff disclose prior to the delivery of any educational activity.
- Lisa A. Carey, MD (Speaker, Contributing Author)
Grants / Research Support – AbbVie, NanoString Techn, Novartis, Seattle Genetics, Syndax, Veracyte
The relationships reported above are related to the following therapeutic area: Hematology-Oncology
The following individuals have no relevant financial relationships with ineligible companies to disclose:
- Meredith Maguire, PA (Speaker)
- Stephanie Joyce, PA, MSPAS, MS, RD (Reviewer)
- Kathleen Duppler (Author)
- Ricardo Correa, MD, EdD, FACP, FACE, FAPCR, FACMQ (Planner)
- Lisa Wakefield, MSN, APRN, FNP-BC (Planner)
All PRIME® staff participating in planning and content development have no relevant financial relationships with ineligible companies to disclose.
Instructions for Participation and Credit
Obtaining CE Credit
- Complete the activity in its entirety
- Complete a post-activity evaluation
- Download and/or print a certificate of completion and/or submit CE credits electronically
Device Requirements
- Computer, smartphone, tablet, or mobile device with audio capabilities and Internet connectivity
Course Viewing Requirements
Supported Browsers:
Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above
Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above
Disclosure of Unlabeled Use
*PRIME® has identified, reviewed, and mitigated all relevant financial relationships that speakers, authors, course directors, planners, peer reviewers, or relevant staff disclose prior to the delivery of any educational activity.
Disclaimer
At PRIME, we are committed to ensuring that individuals with disabilities can access all of the content offered by PRIME through our website and other properties. If you are having trouble accessing primeinc.org, please email [email protected] for assistance. Please put "ADA Inquiry" in the subject line of your email.
Contact Information
Name: PRIME Education Support
Email: [email protected]
Phone: 954-718-6055
URL: https://primece.com/contact-us/